Medical device registration in international markets involves more than obtaining approval in a manufacturer’s home country. Regulatory requirements vary by country and region, including device classification, technical documentation, clinical evidence, labeling, language, and post-market obligations. A device that meets the
Pharmaceutical innovation rarely stays within one market. A new drug, formulation, delivery system, diagnostic technology, or manufacturing process may need patent protection in several countries to support international commercialization. As companies expand their intellectual property (IP) portfolios across borders, pharmaceutical
For medical device manufacturers entering the European market, understanding EU MDR translation requirements is essential for regulatory compliance. Regulation (EU) 2017/745, known as the Medical Device Regulation (MDR), sets requirements for the safety, performance, and market access of medical devices
Clinical trials depend on willing and engaged participants, yet participation can be demanding. Frequent site visits, complex study information, long consent forms, travel requirements, unfamiliar procedures, and language barriers can make trials difficult to navigate. Patient centricity addresses these challenges
As decentralized and hybrid clinical trials become more common, sponsors are using digital technologies to collect clinical outcome data. An eCOA clinical trial can capture patient and clinician information in real time, but implementing these solutions across multiple countries introduces
The Electronic Common Technical Document (eCTD) is the standard format used by pharmaceutical and biotechnology companies to submit regulatory applications electronically to health authorities. It organizes dossier content into a structured format that allows agencies to receive, validate, review, and
Clinical trial findings should be understandable to everyone, especially the patients who participate in the research. However, many trial documents are written for regulators and healthcare professionals, making them difficult for the public to interpret. As transparency and patient engagement
MDR compliance is essential for manufacturers seeking to market medical devices in the European Union. The European Union Medical Device Regulation (EU MDR 2017/745) sets strict requirements to ensure devices meet high standards for safety, performance, and quality throughout their
South Korea is one of Asia’s largest medical technology markets, offering significant opportunities for medical device manufacturers. However, before a device can be imported, marketed, or sold, it must meet the Korean medical device registration requirements set by the Ministry
As clinical trials become increasingly global, the need for accurate Clinical Outcome Assessments (COAs) translation continues to grow. Pharmaceutical companies and Contract Research Organizations (CROs) are conducting studies across multiple regions, requiring patient assessments to be available in different languages
As the life sciences industry continues its digital transformation, electronic labeling (e-labeling) is becoming an increasingly important part of regulatory compliance. Instead of relying solely on printed labels and paper Instructions for Use (IFUs), manufacturers can provide approved product information
The European Union’s In Vitro Diagnostic Medical Devices Regulation (IVDR 2017/746) introduced a more rigorous regulatory framework for in vitro diagnostic (IVD) devices. Replacing the In Vitro Diagnostic Directive (IVDD), it places greater emphasis on patient safety, clinical evidence, and
